Recombinant MEGF10 Protein, Human (Fc Tag) Recombinant Proteins The human MEGF10 (XP_016865476.1) (Met1-Gly857) was expressed with the Fc region of human IgG1 at the C-terminus The recombinant human MEGF10 consists 843a.a and predicts a molecular weight of 90.2 kDa.
$ $99 In stock
Formulation: The recombinant human MEGF10 consists 843a.a and predicts a molecular weight of 90.2 kDa.
Source: HEK293 Cells
Usage: Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use

Recombinant MEGF10 Protein, Human (Fc Tag)

Formulation: Recombinant MEGF10 Protein was lyophilized from sterile PBS, pH 7.4.1

Source: HEK293 Cells

Product Name Recombinant MEGF10 Protein, Human (Fc Tag)
Product Type Recombinant Protein
Source HEK293 Cells
Formulation Recombinant MEGF10 Protein was lyophilized from sterile PBS, pH 7.4.1
Molecular Weight The recombinant human MEGF10 consists 843a.a and predicts a molecular weight of 90.2 kDa.
Endotoxin < 1.0 EU per μg protein as determined by the LAL method
Purity Greater than 90% as determined by SDS-PAGE.
Description The human MEGF10 (XP_016865476.1) (Met1-Gly857) was expressed with the Fc region of human IgG1 at the C-terminus
Host Species Homo sapiens (Human)
Usage Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use
Storage Store recombinant protein under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
AA Sequence Met1-Gly857
Product Background Multiple-EGF like domains 1 (MEGF1) is the mammalian homologue of Draper, a Drosophila phagocytosis receptor that plays an important role in synapse elimination and cell type-specific recognition.MEGF1 is predominantly expressed in the brain and known to function as a phagocytic receptor.MEGF1 is known to function as a myogenic regulator of satellite cells in skeletal muscle. Mutations in MEGF1 gene cause a congenital myopathy called early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD).
Memo EMARDD Protein, Human
Terminal Leu 26
Bioactivity Please contact us for detailed information